Abeona therapeutics announces $25 million registered direct offering priced at-the-market under nasdaq rules

Cleveland, july 03, 2023 (globe newswire) -- abeona therapeutics inc. (nasdaq: abeo) today announced that it has raised $25 million at-the-market from select existing investors, primarily to fund initiation of the company's launch preparations in anticipation of the eb-101 biologics license application (bla) submission and potential approval.
ABEO Ratings Summary
ABEO Quant Ranking